Hindustan Aeronautics Ltd (HAL), a leading defence manufacturer, has received mixed reactions from Dalal Street analysts following its June quarter results. While the stock generally holds a 'Buy' consensus, a notable 17 percent rally over the past six months has prompted some analysts to express caution regarding its risk-reward profile, suggesting limited further upside.
Q1 Performance and Analyst Insights
InCred Equities highlighted that HAL's Q1 performance appeared to be a 'beat on paper' rather than reflecting operational strength. Gross margin compression was reportedly offset by higher other income and reduced operational expenses, which flattered the overall headline results. InCred noted that HAL's earnings quality has heavily relied on other income (approximately 25-30 percent of profit before tax) between FY22-26, boosted by a favorable MRO mix and front-loaded large orders in FY25.
Looking forward, InCred forecasts a shift, anticipating margins, other income, and cash flow to roll over as capex ramps up and the product mix changes. The current backlog of Rs 2.5 lakh crore is considered a cyclical peak for the next 2-3 years. Consequently, InCred maintains a 'Hold' rating on HAL with a target price of Rs 4,550, expecting a higher product mix to eventually outweigh margin pressures, while a Rs 15,000 crore capex plan over 3-4 years is projected to impact cash accruals and working capital.
Varying Brokerage Outlooks
Anand Rathi, despite the re-rating already capturing much of the positive sentiment, retains a 'Buy' rating on HAL, setting a target price of Rs 5,431. The brokerage cites improving execution as a key support for its positive view, identifying Mk-1A testing in September and delivery milestones as crucial near-term catalysts. HAL shares are currently trading at 35.9 times Anand Rathi's estimated FY27 earnings per share.
Conversely, Nuvama has downgraded HAL to a 'Hold' rating. This decision follows the stock breaching its previous target and weaker-than-expected product-led execution limiting further upside. Nuvama values the stock at 30 times FY28E EPS, factoring in a 14 percent revenue CAGR and 10 percent EPS CAGR, along with 30 percent EBITDA margins by FY28E, resulting in an unchanged target of Rs 5,040.
On the more optimistic side, foreign brokerage Nomura maintains a positive stance, considering HAL its top pick in the defence sector. Nomura reported that HAL surpassed its Q1 estimates across all metrics, with healthy visibility driven by its manufacturing order book. While their earnings estimates remain largely consistent, Nomura projects a PAT CAGR of 19 percent over FY26-29F. The brokerage rolled forward its valuation to 30x September 2028 EPS of Rs 211, raising its target price to Rs 6,314 from Rs 6,040.
Disclaimer: This report provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.